WINNIPEG, Manitoba, Nov. 02, 2023 (GLOBE NEWSWIRE) Kane Biotech Inc. (TSXV:KNE, OTCQB:KNBIF) (the "Company" or "Kane Biotech") in partnership with ProgenaCare Global LLP ("ProgenaCare") today announces the launch of
Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve™ Antimicrobial Wound Gel at Advanced Wound Care Fall Forum tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyvetm Antimicrobial Wound Gel at Advanced Wound Care Fall Forum lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
68% Increase in Product and Services Revenue; 74% Increase in Royalties Revenue WINNIPEG, Manitoba, Aug. 29, 2023 Kane Biotech Inc. today announced its second quarter 2023 financial.